“Byetta lawsuits have been going on for several years in California state courts,” Stewart says. “They are currently trying Byetta cancer cases involving thyroid and pancreatic cancer, but there is no conclusion to those cases that I’m aware of. Lawsuits alleging pancreatitis linked to Byetta have been settled in California. Meanwhile, Januvia cases are currently just being filed. Januvia litigation has not moved very far through the court system yet, although we anticipate it will be assembled into a multidistrict litigation, which would consolidate discovery outside of California. That probably will not happen for 90 days, though.”
Actos lawsuits alleging bladder cancer are currently broken into two different actions, according to Stewart. The first is a multidistrict litigation in Louisiana, where discovery is ongoing. The second action is in California and was originally filed in state court for California residents. After litigation started, however, non-domestic cases (meaning those in which plaintiffs lived in other states) were allowed to be included in the action.
“The first Actos cases are on the verge of being tried in Chicago as bellwether cases, which show the defendants a determination of the value of the case and also show both sides the strengths and weaknesses of the arguments,” Stewart says. “Shortly thereafter, we expect cases to be tried in California state courts.”
READ MORE ACTOS SIDE EFFECTS LEGAL NEWS
Regarding Januvia lawsuits, patients must have been diagnosed with acute, chronic pancreatitis, not just pancreatitis. Meanwhile, Januvia patients who have been diagnosed with hyperthyroidism may not be eligible to file a lawsuit, but should consider medical monitoring because hyperthyroidism can be a precursor to thyroid cancer.
“Those patients should be continually monitored to ensure the hyperthyroidism doesn’t develop into cancer,” Stewart says. “The longer patients wait for intervention once it becomes cancer, the more difficult recovery is.”